Blood test may predict heart pump surgery risks
NCT ID NCT07497308
First seen Mar 28, 2026 · Last updated May 13, 2026 · Updated 8 times
Summary
This study is checking if a blood marker called GDF-15 can help doctors predict early complications and death in people with advanced heart failure who are getting a mechanical heart pump (LVAD). Researchers will measure GDF-15 levels before surgery in about 48 adults and then track their recovery. The goal is to improve risk assessment and identify high-risk patients before the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Akdeniz University, Faculty of Medicine, Department of Anesthesiology and Reanimation
RECRUITINGAntalya, Please Select:, 07050, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.